Letters 4. Oral chemotherapy drugs. CareFirst. https://member.carefirst.com/carefirst- in eligibility criteria but also throughout the process of resources/pdf/oral-chemotherapy-drug-list-sum2714.pdf. Published 2017. screening initiation and cancer diagnosis, treatment, and Accessed June 2, 2019. survivorship. 5. Bennette CS, Richards C, Sullivan SD, Ramsey SD. Steady increase in prices for oral anticancer drugs after market launch suggests a lack of competitive Hilary A. Robbins, PhD pressure. Health Aff (Millwood). 2016;35(5):805-812. doi:10.1377/hlthaff.2015. Mattias Johansson, PhD 6. Prasad V, Mailankody S. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern Med. Author Affiliations: International Agency for Research on Cancer, Lyon, France. 2017;177(11):1569-1575. doi:10.1001/jamainternmed.2017.3601 Corresponding Author: Hilary A. Robbins, PhD, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69008, France (robbinsh @iarc.fr). COMMENT & RESPONSE Published Online: November 7, 2019. doi:10.1001/jamaoncol.2019.4598 Conflict of Interest Disclosures: None reported. Defining Equity in Eligibility for Cancer Screening Disclaimer: The authors alone are responsible for the views expressed in this To the Editor Aldrich et al reported that according to the cur- article and do not necessarily represent the views, decisions, or policies of the rent US lung cancer screening criteria set forth by the US Pre- institution with
JAMA Oncology – American Medical Association
Published: Jan 7, 2020
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera